[ 2 ] Hezel AF, Zhu AX. Systemic therapy for biliary tract cancers[J]. Oncologist, 2008, 13(4): 415-423.
[3]
[ 3 ] Ebata T, Nagino M, Kamiya J, et al. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases[J]. Ann Surg, 2003, 238(5): 720-727.
[4]
[ 4 ] Rea DJ, Munoz-Juarez M, Farnell MB, et al. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients[J]. Arch Surg, 2004, 139(5): 514-523.
Khan SA, Davidson BR, Gold IR, et al. Guide lines for the diagnosis and treatment of cholangiocarcinoma: consensus document[J]. Gut, 2002, 51(Suppl 6): s7-s9.
[11]
Ribero D, Amisano M, Lo Tesoriere R, et al. Additional resection of an intraoperative margin-positive proximal bile duct improves survival in patients with hilar cholangiocarcinoma[J]. Ann Surg, 2011, 254(5): 776-781.
De Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment[J]. J Clin Oncol, 2011, 29(23): 3140-3145.
[14]
Shiba H, Ishida Y, Wakiyama S, et al. Negative impact of blood transfusion on recurrence and prognosis of hepatocellular carcinoma after hepatic resection[J]. J Gastrointest Surg, 2009, 13(9): 1636-1642.
